SCHEMBL2491574

SCHEMBL2491574

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1OCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 5/20 0.38
GAA P10253 5/20 0.38
SI P14410 5/20 0.38
MGAM2 Q2M2H8 5/20 0.38
ADRB2 P07550 1/20 0.35
CREB1 P16220 1/20 0.34
SOAT1 P35610 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
ABCB1 P08183 1/20 0.34
HTR7 P34969 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
PTPN1 P18031 1/20 0.33
PDE4B Q07343 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
CDC7 O00311 1/20 0.32
PLK4 O00444 1/20 0.32
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491466 0.92 LTA4H (0.40) SOAT1HDAC8PTPN1CDC7PLK4
SCHEMBL2494994 0.87 ALDH1A1 (0.36) GAAADRB2ADORA3PDE4BPDE4A
SCHEMBL2492749 0.78 PDE4B (0.47) MGAMGAASIMGAM2PDE4B
SCHEMBL16575421 0.77 PDE4A (0.44) MGAMGAASIMGAM2CREB1
SCHEMBL14318446 0.74 ADRB2 (0.45) ADRB2CREB1SOAT1ADORA3HDAC8
SCHEMBL5764075 0.74 HDAC8 (0.43) MGAMGAASIMGAM2CREB1
SCHEMBL10457132 0.74 LTA4H (0.40) SOAT1HDAC8PTPN1CDC7PLK4
SCHEMBL29274196 0.73 ALDH1A1 (0.40) GAAADRB2ADORA3PDE4BPDE4A
SCHEMBL2492230 0.72 GCGR (0.38) GAAADRB2ADORA3
SCHEMBL2491463 0.71 GCGR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MGAM 3195/4885GAA 1009/4885SI 4514/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MGAM 2958/4885GAA 986/4885SI 4570/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MGAM 3025/4885GAA 1068/4885SI 4586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.